BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35784397)

  • 21. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer.
    van Griethuysen JJM; Lambregts DMJ; Trebeschi S; Lahaye MJ; Bakers FCH; Vliegen RFA; Beets GL; Aerts HJWL; Beets-Tan RGH
    Abdom Radiol (NY); 2020 Mar; 45(3):632-643. PubMed ID: 31734709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability and Reproducibility of Radiomic Features Based Various Segmentation Technique on MR Images of Hepatocellular Carcinoma (HCC).
    Haniff NSM; Abdul Karim MK; Osman NH; Saripan MI; Che Isa IN; Ibahim MJ
    Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Magnetic Resonance Imaging of the Lower Uterine Segment in Pregnant Women with Central Placenta Previa with and without Placenta Accreta Spectrum from a Single Center.
    Hou S; Song Y; Wu J; Zhou L; Kang S; Chen X; Zhang L; Lu Y; Yue Y
    Med Sci Monit; 2021 Oct; 27():e932759. PubMed ID: 34675167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying magnetic resonance imaging features to classify placenta accreta spectrum (PAS) in high-risk gravid patients.
    Chu C; Liu M; Zhang Y; Yu L; Wang D; Gao C; Li W
    Clin Imaging; 2021 Dec; 80():50-57. PubMed ID: 34242814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
    Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
    Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
    Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
    J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.
    Cavalli C; Maggi C; Gambarini S; Fichera A; Santoro A; Grazioli L; Prefumo F; Odicino FE; Fratelli N
    J Perinat Med; 2022 Mar; 50(3):277-285. PubMed ID: 34854274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
    Calí G; Timor-Tritsch IE; Forlani F; Palacios-Jaraquemada J; Monteagudo A; Kaelin Agten A; Flacco ME; Khalil A; Buca D; Manzoli L; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):450-459. PubMed ID: 31788885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
    Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
    J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USMRI Features and Clinical Data-Based Model for Predicting the Degree of Placenta Accreta Spectrum Disorders and Developing Prediction Models.
    An P; Zhang J; Yang F; Wang Z; Hu Y; Li X
    Int J Clin Pract; 2022; 2022():9527412. PubMed ID: 35685563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placenta accreta spectrum: value of placental bulge as a sign of myometrial invasion on MR imaging.
    Jha P; Rabban J; Chen LM; Goldstein RB; Weinstein S; Morgan TA; Shum D; Hills N; Ohliger MA; Poder L
    Abdom Radiol (NY); 2019 Jul; 44(7):2572-2581. PubMed ID: 30968183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple U-Net-Based Automatic Segmentations and Radiomics Feature Stability on Ultrasound Images for Patients With Ovarian Cancer.
    Jin J; Zhu H; Zhang J; Ai Y; Zhang J; Teng Y; Xie C; Jin X
    Front Oncol; 2020; 10():614201. PubMed ID: 33680934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome.
    Delli Pizzi A; Tavoletta A; Narciso R; Mastrodicasa D; Trebeschi S; Celentano C; Mastracchio J; Cianci R; Seccia B; Marrone L; Liberati M; Cotroneo AR; Caulo M; Basilico R
    Abdom Radiol (NY); 2019 May; 44(5):1873-1882. PubMed ID: 30600374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of placental location in cases of placenta accreta spectrum.
    Morgan EA; Sidebottom A; Vacquier M; Wunderlich W; Loichinger M
    Am J Obstet Gynecol; 2019 Oct; 221(4):357.e1-357.e5. PubMed ID: 31344349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravoxel incoherent motion MR imaging analysis for diagnosis of placenta accrete spectrum disorders: A pilot feasibility study.
    León RL; Brown BP; Persohn SA; Norris CD; Steinhardt NP; Lin C; Territo PR
    Magn Reson Imaging; 2021 Jul; 80():26-32. PubMed ID: 33766730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 39. Lower uterine segment scar assessment at 11-14 weeks' gestation to screen for placenta accreta spectrum in women with prior Cesarean delivery.
    Bhatia A; Palacio M; Wright AM; Yeo GSH
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):40-48. PubMed ID: 34254386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
    Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
    Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.